These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16949139

  • 1. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors.
    Kipp M, Karakaya S, Pawlak J, Araujo-Wright G, Arnold S, Beyer C.
    Front Neuroendocrinol; 2006 Dec; 27(4):376-90. PubMed ID: 16949139
    [Abstract] [Full Text] [Related]

  • 2. Classical and nonclassical estrogen action in the developing midbrain.
    Küppers E, Ivanova T, Karolczak M, Lazarov N, Föhr K, Beyer C.
    Horm Behav; 2001 Sep; 40(2):196-202. PubMed ID: 11534982
    [Abstract] [Full Text] [Related]

  • 3. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK.
    Neuroscience; 2008 Jun 23; 154(2):606-20. PubMed ID: 18472226
    [Abstract] [Full Text] [Related]

  • 4. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO.
    Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466
    [Abstract] [Full Text] [Related]

  • 5. Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.
    Marchionini DM, Lehrmann E, Chu Y, He B, Sortwell CE, Becker KG, Freed WJ, Kordower JH, Collier TJ.
    Brain Res; 2007 May 25; 1147():77-88. PubMed ID: 17368428
    [Abstract] [Full Text] [Related]

  • 6. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM, Lee CR.
    Prog Brain Res; 2007 May 25; 160():189-208. PubMed ID: 17499115
    [Abstract] [Full Text] [Related]

  • 7. Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra.
    Smidt MP, Smits SM, Burbach JP.
    Cell Tissue Res; 2004 Oct 25; 318(1):35-43. PubMed ID: 15300495
    [Abstract] [Full Text] [Related]

  • 8. Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.
    Dluzen D, Horstink M.
    Endocrine; 2003 Jun 25; 21(1):67-75. PubMed ID: 12777705
    [Abstract] [Full Text] [Related]

  • 9. Unconventional effects of estrogen uncovered.
    Dluzen DE.
    Trends Pharmacol Sci; 2005 Oct 25; 26(10):485-7. PubMed ID: 16122814
    [Abstract] [Full Text] [Related]

  • 10. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
    Anderson LI, Leipheimer RE, Dluzen DE.
    Neuroscience; 2005 Oct 25; 130(2):369-82. PubMed ID: 15664693
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cell type-specificity of nonclassical estrogen signaling in the developing midbrain.
    Beyer C, Ivanova T, Karolczak M, Küppers E.
    J Steroid Biochem Mol Biol; 2002 Aug 25; 81(4-5):319-25. PubMed ID: 12361721
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target.
    Arnold S, Beyer C.
    J Neurochem; 2009 Jul 25; 110(1):1-11. PubMed ID: 19457121
    [Abstract] [Full Text] [Related]

  • 14. Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons.
    Küppers E, Ivanova T, Karolczak M, Beyer C.
    J Neurocytol; 2000 Jul 25; 29(5-6):375-85. PubMed ID: 11424954
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice.
    Küppers E, Krust A, Chambon P, Beyer C.
    Psychoneuroendocrinology; 2008 Jul 25; 33(6):832-8. PubMed ID: 18472350
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
    Hodaie M, Neimat JS, Lozano AM.
    Neurosurgery; 2007 Jan 25; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.